Barr Pharmaceuticals Inc.

Private Subsidiary, Headquarters Location
225 Summit Ave., Montvale, NJ 07645-1523, United States
(800)222-0190, (201)930-3300, http://www.barrlabs.com

Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Barr Pharmaceuticals Inc. is a Delaware holding company formed through a reincorporation merger in December 2003. Its predecessor entity, a New York corporation, was formed in 1970 and began active operations in 1972. The company is a global pharmaceutical company operating primarily in North America and Europe, with its key markets being the U.S., Croatia, Germany, Poland and Russia. It is primarily engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals. In addition, the company is developing generic biologic products. Its generic product portfolio includes solid oral dosage forms, injectables, liquids and cream/ointment products. In the U.S., its largest market, its generic products are marketed under the Barr label. As of December 2007, the company manufactured and marketed 25 generic oral contraceptive products, including Aviane, Kariva and Tri-Sprintec, outside of the U.S. The company manufactures and markets proprietary pharmaceutical products under the Duramed label in the U.S. and Canada, with its portfolio primarily focused on female healthcare, including the contraceptives Seasonique, Plan B and Mircette. As of December 2007, the company's biologic products were in development for the U.S. and European markets. In October 2006, the company acquired PLIVA, a generic pharmaceutical company headquartered in Zagreb, CroatiaManufacturing: Pharmaceutical products, including those related to oncology, female healthcare (including hormone replacement and oral contraceptives), cardiovascular, anti-infectives and psychotherapeutics.